Jian-li G. Jiang

Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

A fully human antibody A140 neutralizes abrin toxin via lysosomal intracellular mechanisms, confers potent protection in vitro and in vivo, and reverses transcriptomic dysregulation with a Favorable safety profile.

A fully human antibody A140 neutralizes abrin toxin via lysosomal intracellular mechanisms, confers potent protection in vitro and in vivo, and reverses transcriptomic dysregulation with a Favorable safety profile.

Journal: Toxicology and applied pharmacology

Published: March 25, 2026

Correction: CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma.

Correction: CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 15, 2024

Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial.

Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial.

Journal: Signal transduction and targeted therapy

Published: November 01, 2024

Tobacco Smoking Rewires Cell Metabolism by Inducing GAPDH Succinylation to Promote Lung Cancer Progression.

Tobacco Smoking Rewires Cell Metabolism by Inducing GAPDH Succinylation to Promote Lung Cancer Progression.

Journal: Cancer research

Published: September 27, 2024

Integrative insights into the role of CAV1 in ketogenic diet and ferroptosis in pancreatic cancer.

Integrative insights into the role of CAV1 in ketogenic diet and ferroptosis in pancreatic cancer.

Journal: Cell death discovery

Published: August 04, 2024

Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway.

Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway.

Journal: Cell communication and signaling : CCS

Published: July 22, 2024

Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity.

Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity.

Journal: MedComm

Published: November 26, 2023

Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer.

Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer.

Journal: Cell death discovery

Published: September 11, 2023

Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosis.

Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosis.

Journal: Journal of pharmaceutical analysis

Published: March 06, 2023

Id2 epigenetically controls CD8+ T-cell exhaustion by disrupting the assembly of the Tcf3-LSD1 complex.

Id2 epigenetically controls CD8+ T-cell exhaustion by disrupting the assembly of the Tcf3-LSD1 complex.

Journal: Cellular & molecular immunology

Published: July 31, 2022

PDGFA-associated protein 1 is a novel target of c-Myc and contributes to colorectal cancer initiation and progression.

PDGFA-associated protein 1 is a novel target of c-Myc and contributes to colorectal cancer initiation and progression.

Journal: Cancer communications (London, England)

Published: January 21, 2022

Intermittent fasting reduces neuroinflammation in intracerebral hemorrhage through the Sirt3/Nrf2/HO-1 pathway.

Intermittent fasting reduces neuroinflammation in intracerebral hemorrhage through the Sirt3/Nrf2/HO-1 pathway.

Journal: Journal of neuroinflammation

Published: October 28, 2021

Showing 1-12 of 52

Last Updated: 09/26/2026